EV/EBITDA:
-14.20-0.70(-5.19%)Summary
- As of today, APGE EV/EBITDA is -14.20, with a fall of -0.70 (-5.19%) during the most recent trading session on November 21, 2025.
- Over the past year, APGE EV/EBITDA has dropped by -3.39 (-31.36%).
- APGE EV/EBITDA is now -182.87% below its all-time high of -5.02.
Performance
APGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -5.2% | +5.2% | +4.6% |
| 1M1 Month | -22.9% | +22.9% | +18.6% |
| 3M3 Months | -129.4% | +139.8% | +82.3% |
| 6M6 Months | -86.1% | +117.7% | +64.9% |
| YTDYTD | -40.7% | +83.5% | +46.3% |
| 1Y1 Year | -31.4% | +108.3% | +54.6% |
| 5Y5 Years | - | - | - |
APGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -10.94 | -29.8% | -14.20 | at low |
| 3M | 3-Month | -6.19 | -129.4% | -14.20 | at low |
| 6M | 6-Month | -5.81 | -144.4% | -14.20 | at low |
| 1Y | 1-Year | -5.02 | -182.9% | -14.20 | at low |
| 3Y | 3-Year | -5.02 | -182.9% | -38.03 | +62.7% |
| 5Y | 5-Year | -5.02 | -182.9% | -38.03 | +62.7% |
| All-Time | All-Time | -5.02 | -182.9% | -38.03 | +62.7% |
APGE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -14.20(-40.7%) |
| Date | Value |
|---|---|
| 2024 | -10.09(+2.5%) |
| 2023 | -10.35 |
FAQ
- What is Apogee Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Apogee Therapeutics, Inc.?
- What is APGE EV/EBITDA year-to-date change?
- What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Apogee Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of APGE is -14.20
What is the all-time high EV/EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high EV/EBITDA is -5.02
What is APGE EV/EBITDA year-to-date change?
Apogee Therapeutics, Inc. EV/EBITDA has changed by -4.11 (-40.73%) since the beginning of the year
What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, APGE EV/EBITDA has changed by -3.39 (-31.36%)